Showing results (261-270 of 281) with videos related to
Sort By:
Pageof 29
Journal of Hematology & Oncology|April 17, 2020
Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter studyChang Lu, Xiao-Rong Dong, Jun Zhao, et al.Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancerHai-Yan Tu, E-E Ke, Jin-Ji Yang, et al.Cancer Discovery|May 11, 2022
Longitudinal Undetectable Molecular Residual Disease Defines Potentially Cured Population in Localized Non-Small Cell Lung CancerJia-Tao Zhang, Si-Yang Liu, Wei Gao, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 19, 2023
Allelic Context of EGFR C797X-Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical OutcomesChang Lu, Xue-Wu Wei, Zhen Wang, et al.JTO Clinical and Research Reports|January 3, 2022
Real-World Survival Outcomes Based on <i>EGFR</i> Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN StudyXue-Ning Yang, Hong-Hong Yan, Jun Wang, et al.Cell Reports|August 8, 2024
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLCYang-Si Li, Wen-Pu Lai, Kai Yin, et al.Journal for Immunotherapy of Cancer|November 28, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastasesYang-Si Li, Wenpu Lai, Kai Yin, et al.Nature Medicine|February 27, 2025
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastasesMei-Mei Zheng, Qing Zhou, Hua-Jun Chen, et al.Nature Communications|November 9, 2021
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomesSi-Yang Liu, Hua Bao, Qun Wang, et al.Translational Lung Cancer Research|July 28, 2018
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panelYi-Long Wu, Chang-Li Wang, Mei-Lin Liao, et al.Pageof 29